VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical has teamed up with Japan-based alternative asset management firm, Whiz Partners to create a joint investment fund, aimed at promoting a drug discovery ecosystem in Japan. 3 August 2018
Biotechnology
UK-based antiviral drug discovery and development company ReViral today announced the successful completion of a $55 million Series B financing. 1 August 2018
Biotechnology
One year after raising $800 million in a follow-on public offering, BeiGene has announced it will list on the Hong Kong stock exchange with an initial public offering (IPO) expected to bring in an even greater sum for the Beijing-based firm. 27 July 2018
Biotechnology
In the 1980s, technologies such as DNA editing started to mature, creating a range of sophisticated and transformative therapeutic techniques - and a race to secure funding, technologies and expertise. 27 July 2018
Biotechnology
Today San Francisco, USA-based biotech start-up Alector announced the closing of a $133 million Series E financing and for the first time revealed its first three programs focused on Alzheimer’s disease and frontotemporal dementia (FTD). 25 July 2018
Pharmaceutical
Sanofi Ventures, the investment arm of French pharma major Sanofi has entered into a $17 million deal with New York-based Click Therapeutics. 23 July 2018
Biotechnology
Shares of French biotech TxCell soared more than 151% to 2.33 euros on the news of a takeover bid for the company. 23 July 2018
Biotechnology
Chinese biopharma start-up Ascentage Pharma has announced the successful completion of approximately $150 million in a Series C financing, bringing the total capital raised since the Company's launch to around $240 million. 17 July 2018
Biotechnology
East Coast, USA-based I-O startup Compass Therapeutics has finished raising $132 million to take its lead candidate into the clinic and identify two more clinical candidates. 13 July 2018
Pharmaceutical
UK-based health-oriented foundation the Wellcome Trust has announced a quarter-billion pound ($330 million) fund to “back bold ideas.” 11 July 2018
Pharmaceutical
Medicinal cannabis has been a hot topic in the USA and the UK in recent weeks, and an Australian company joined the party on Thursday with some news of its own. 5 July 2018
Biotechnology
Dutch biotech company VarmX, which focuses on the development of therapies in the field of hemostasis and thrombosis, today announced the closing of a Series A financing round of 7.5 million euros ($8.8 million). 2 July 2018
Biotechnology
I-Mab Biopharma, a Chinese biotech company focusing on innovative biologics in therapeutic areas of immuno-oncology and immuno-inflammation, has completed a Series C financing for $220 million, representing one of the largest amounts ever raised in Series C by an innovative biotech company in China. 2 July 2018
Biotechnology
Illinois-based pharma major AbbVie has renewed its partnership with Calico, the Alphabet subsidiary dedicated to combating the effects of aging. 27 June 2018
Biotechnology
Cambridge, Massachusetts-based Skyhawk Therapeutics has entered into a global strategic collaboration with an affiliate of US biotech major Celgene to discover, develop and commercialize innovative small molecule treatment options for patients with neurological diseases based on Skyhawk's innovative STAR* technology platform. 26 June 2018
Biotechnology
iTeos Therapeutics, a biotech developing novel cancer immunotherapies, has announced the completion of an oversubscribed $75 million Series B financing in the latest example of major investment in immuno-oncology (I-O). 20 June 2018
Biotechnology
Independent mitochondrial DNA specialist Stealth BioTherapeutics has raised $100 million from Nan Fung Technology’s Pivotal Beta and other new and existing investors. 20 June 2018
Biotechnology
Less than a week after setting up two new companies with a $35 million investment, life sciences trust Syncona is making more waves in gene therapy by contributing £85 million ($112 million) to Freeline Therapeutics' Series B funding campaign. 20 June 2018
Biotechnology
Israel-based Galmed Pharmaceuticals has priced its previously announced underwritten public offering of 5,000,000 ordinary shares, at a public offering price of $15.00 per share. 20 June 2018
Biotechnology
A privately-held UK company has picked up a £1 million ($1.3 million) grant for its work on a formulation platform to develop a portfolio of proprietary products enabling improved treatments for diabetes care. 18 June 2018
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze